CN111990510A - Composite instant tea - Google Patents
Composite instant tea Download PDFInfo
- Publication number
- CN111990510A CN111990510A CN202010895286.XA CN202010895286A CN111990510A CN 111990510 A CN111990510 A CN 111990510A CN 202010895286 A CN202010895286 A CN 202010895286A CN 111990510 A CN111990510 A CN 111990510A
- Authority
- CN
- China
- Prior art keywords
- parts
- extraction
- raw materials
- instant tea
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000020344 instant tea Nutrition 0.000 title claims abstract description 17
- 239000002131 composite material Substances 0.000 title claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 15
- 238000001914 filtration Methods 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 8
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 7
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 7
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 7
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 7
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000004806 packaging method and process Methods 0.000 claims abstract description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract 3
- 240000007171 Imperata cylindrica Species 0.000 claims abstract 3
- 238000000605 extraction Methods 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000002386 leaching Methods 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- 230000002829 reductive effect Effects 0.000 claims description 8
- 244000111489 Gardenia augusta Species 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 240000001910 Momordica cochinchinensis Species 0.000 claims description 3
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 abstract description 32
- 241000411851 herbal medicine Species 0.000 abstract description 5
- 244000269722 Thea sinensis Species 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 235000013616 tea Nutrition 0.000 abstract description 2
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 13
- 150000004676 glycans Chemical class 0.000 description 13
- 229920001282 polysaccharide Polymers 0.000 description 13
- 239000005017 polysaccharide Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 241000723353 Chrysanthemum Species 0.000 description 5
- 238000002137 ultrasound extraction Methods 0.000 description 5
- 241001598107 Imperata Species 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000034507 Haematemesis Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of health-care tea, and particularly relates to composite instant tea, (1) preparing and mixing raw materials; the raw materials comprise the following components: 90-110 parts of dendrobium officinale leaf, 27-33 parts of chrysanthemum, 45-55 parts of kudzu root, 18-22 parts of gardenia fruit and 4.5-5.5 parts of lophatherum gracile; 9-11 parts of cogongrass rhizome and 9-11 parts of houttuynia cordata; (2) primary crushing: a medium-speed crusher is adopted, the rotating speed is 1000-; (3) cleaning; (4) extracting; (5) filtering; (6) concentrating; (7) drying; (8) granulating; (9) drying; (10) and (6) packaging. The invention provides composite instant tea which is obtained by extracting a plurality of medicinal and edible Chinese herbal medicines with liver nourishing and protecting functions in specific proportions after compatibility, and pharmacological tests prove that the composite instant tea has better liver nourishing and protecting functions, is strong in pertinence, is instant and portable, and is particularly suitable for fast-paced office workers.
Description
Technical Field
The invention belongs to the field of health-care tea, and particularly relates to compound instant tea.
Background
The liver is an important organ of a human body and has the functions of regulating qi and blood, helping the spleen and stomach digest food and absorb nutrition, and has the functions of regulating emotion and regulating qi. Modern city office workers generally use computers to work, smoke and wine are endless, life is not restrained at night, and the liver qi is directly injured when people stay up at night. The traditional Chinese medicine considers that the liver governs the eyes: "liver qi is passed through eyes, and liver and eyes can distinguish five colors ". Liver diseases usually affect the eyes. If liver blood is insufficient, eyes are dry, blurred vision or night blindness; red, itching and pain of eyes can be seen due to wind-heat in liver channel; flaming up of liver fire, visible nebula with red eyes; hyperactivity of liver yang can lead to dizziness and vertigo; the liver wind moves inwards, so that the eyes look obliquely upward. In addition, when people sit for a long time, the eyes are not enough in binocular blood supply, and the cervical vertebra and the lumbar vertebra also strain and are not always relieved, so that the liver is damaged. Under the condition, the symptoms of fatigue of eyes, visual deterioration, even sallow complexion and dizziness appear, which is not strange. Long-term vision and radiation, which pose hidden dangers for the eye health of computer people.
The liver plays an important role in the detoxification of human body, and the reasonable nutrition preparation can improve the detoxification capability of the liver. Nourishing and protecting liver mainly aims at clearing liver toxicity, purging liver fire, soothing liver and regulating qi. The liver can be nourished and conditioned by frequently drinking some Chinese herbal medicines with the functions of nourishing and protecting the liver. At present, time-verified medicinal and edible Chinese herbal medicines with liver nourishing and protecting functions in the market have more formulas, but the medicines need to be decocted and are time-consuming and inconvenient to take, and particularly, the medicines are difficult to continuously take for fast-paced urban office workers and are difficult to play a daily health care role.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide composite instant tea.
The technical scheme adopted by the invention is as follows: the composite instant tea comprises the following raw materials:
90-110 parts of dendrobium officinale leaf, 27-33 parts of chrysanthemum, 45-55 parts of kudzu root, 18-22 parts of gardenia fruit and 4.5-5.5 parts of lophatherum gracile; 9-11 parts of cogongrass rhizome, 9-11 parts of houttuynia cordata and 13.5-16.5 parts of dried momordica cochinchinensis fruit;
the preparation process comprises the following steps:
(1) preparing and mixing raw materials;
(2) primary crushing: a medium-speed crusher is adopted, the rotating speed is 1000-;
(3) cleaning: cleaning the mixed raw materials after the primary crushing, and filtering to dry;
(4) extraction: adding the cleaned mixed raw materials into water for extraction;
(5) and (3) filtering: filtering to remove particles larger than 1 μm;
(6) concentrating;
(7) and (3) drying: drying by spray drying or freeze drying;
(8) and (3) granulation: granulating to form granules;
(9) drying;
(10) and (6) packaging.
The invention is obtained by extracting a plurality of medicinal and edible Chinese herbal medicines with liver nourishing and protecting functions in specific proportions after compatibility.
The dendrobium officinale leaves have the effects of protecting liver, expelling toxin, promoting the production of body fluid, nourishing stomach, nourishing yin, clearing heat, moistening lung, tonifying kidney, improving eyesight, strengthening waist and improving human immunity.
The chrysanthemum has the effects of clearing heat and removing toxicity, comfortably dissipating heat, dissipating blood stasis, improving eyesight and reducing blood pressure. Modern medical research proves that the chrysanthemum has the functions of reducing blood pressure, eliminating cancer cells, dilating coronary artery and inhibiting bacteria.
Kudzu vine root, clearing away fire, dispelling the effects of alcohol and protecting liver, expelling toxin, reducing blood fat, blood pressure and cholesterol, reducing blood sugar, losing weight, preventing senile dementia and preventing cardiovascular and cerebrovascular diseases.
Gardenia fruit has the effects of clearing heat, purging fire, cooling blood, protecting liver and benefiting gallbladder. It is used to treat febrile diseases, vexation, insomnia, jaundice, gonorrhea, diabetes, conjunctival congestion, pharyngalgia, hematemesis, epistaxis, dysentery with blood, hematuria, pyocutaneous disease due to heat toxin, sprain, and swelling and pain.
Lophatherum gracile has the effects of cooling, relieving fever and promoting urination, and is mainly used for treating the following diseases: chest fever, cough, dyspnea, hematemesis, toxic heat wind, thirst, erysipelas, phlegm, mania, dysphoria, aphonia due to apoplexy, headache, palpitation, epidemic, vexation, insect killing, and spleen relieving.
Lalang grass rhizome, rhizoma Imperatae, cools blood to stop bleeding, clears heat and induces diuresis. Can be used for treating hematemesis due to blood heat, epistaxis, hematuria, fever polydipsia, cough due to lung heat, stomach heat emesis, jaundice due to damp-heat pathogen, edema oliguria, stranguria with astringency and pain.
The heartleaf houttuynia herb has the effects of clearing heat and removing toxicity, eliminating carbuncle and discharging pus, inducing diuresis for treating strangurtia, diminishing inflammation and resisting viruses, improving the immunity of the organism and inducing diuresis.
Preferably, the raw materials comprise the following components:
100 parts of dendrobium officinale leaf, 30 parts of chrysanthemum, 50 parts of kudzu root, 20 parts of gardenia fruit and 5 parts of lophatherum gracile; 10 parts of cogongrass rhizome, 10 parts of houttuynia cordata and 15 parts of dried momordica cochinchinensis fruit.
In the step (4), the extraction process comprises soaking, heating and ultrasonic leaching, and then vacuum decompression extraction.
In the step (4), the extraction process is as follows:
(4-1) soaking at 4-8 ℃;
(4-2) ultrasonic leaching: heating to 60-100 deg.C, ultrasonic extracting, and keeping the temperature;
(4-3) leaching under reduced pressure: rapidly cooling to below 25 deg.C, and vacuum extracting under reduced pressure.
In the step (4-2), the mixture is heated to 80 ℃, is subjected to ultrasonic leaching for 10 to 15 minutes at the frequency of 40KHZ, is placed into an extraction tank, and is kept at the temperature of 80 ℃ for 1 hour.
The invention has the following beneficial effects: the invention provides composite instant tea which is obtained by extracting a plurality of Chinese herbal medicines with liver nourishing and protecting functions in a specific proportion after compatibility, and pharmacological tests prove that the composite instant tea has better liver nourishing and protecting functions, is strong in pertinence, is instant and portable, and is particularly suitable for fast-paced office workers.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is within the scope of the present invention for those skilled in the art to obtain other drawings based on the drawings without inventive exercise.
FIG. 1 is a graph of the effect of ultrasonic extraction temperature on extraction results;
fig. 2 is a graph showing the effect of ultrasound extraction time on extraction efficiency.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in further detail with reference to the accompanying drawings.
The preparation method of the composite instant tea comprises the following specific steps:
(1) raw materials are selected: 100g of dendrobium officinale leaf, 30g of chrysanthemum, 50g of kudzu root, 20g of gardenia fruit, 5g of lophatherum gracile, 10g of lalang grass rhizome and 10g of houttuynia cordata, and mixing.
(2) Primary crushing: using a medium-speed pulverizer at the rotation speed of 1000-;
(3) cleaning and soaking: cleaning the crushed mixed raw materials, and filtering to dry;
(4) extraction: adding the cleaned mixed raw materials into water, and extracting according to the feed-liquid mass ratio of 1: 20;
(5) and (3) filtering: filtering with filter cloth with pore size of 3-5 μm by plate-and-frame filtration, and filtering with ceramic membrane with pore size less than 1 μm;
(6) concentrating under reduced pressure to 50% of the original volume;
(7) blending (adding 5% of maltodextrin and 2% of modified starch);
(8) spray drying;
(9) granulating by a granulator;
(10) drying;
(11) and (6) packaging.
The adopted raw materials are various and have complex components, the extraction process has great influence on the health care effect of the product, and the purpose of the patent is to obtain the extract which can be quickly dissolved in water and has the effect of protecting the liver, so that only water is used as a solvent for extraction in the extraction step to extract the soluble effective components in the raw materials.
The following examples are products obtained using different extraction processes:
example 1:
stirring at 4-8 deg.C for 12h to obtain extract with soluble solid content of 1.2% and plant polysaccharide extraction rate of 2.3%, drying in step (8) to obtain product with less amount, and not completing the subsequent granulating, drying and packaging steps.
Example 2:
stirring at 20-25 deg.C for 12h to obtain extract with soluble solid content of 3.5% and plant polysaccharide extraction rate of 4.9%, drying in step (8) to obtain product 9.2g, adding 5g into 100mL water, stirring, dissolving within 30s to obtain yellow, clear and transparent solution.
Example 3:
stirring at 50-60 deg.C for 12h to obtain extract with soluble solid content of 6.1% and plant polysaccharide extraction rate of 8.9%, granulating to obtain 16.4g product, adding 5g into 100mL water, stirring, dissolving within 30s to obtain yellow, clear and transparent solution.
Example 4:
stirring under reflux for 4h, 8h, and 12h to obtain extractive solutions with soluble solid content of 5.1%, 8.6%, and 8.8%, and plant polysaccharide extraction rate of 5.9%, 6.1%, and 4.8%. Concentrating, drying and granulating the 8h extracting solution to obtain 21.8g of a product, adding 5g of the product into 100mL of water, stirring, and dissolving in 30s to obtain a yellow, clear and transparent solution.
From the above examples, it can be seen that the increase in temperature is helpful for the extraction of soluble solids and plant polysaccharides, but too high a problem has an effect on the extraction rate of plant polysaccharides, and it is suspected that high temperature causes the decomposition of plant polysaccharides.
Example 5:
soaking at 4-8 deg.C for 2 hr, extracting with ultrasonic at 40KHz frequency to 60 deg.C, 70 deg.C, 80 deg.C, 90 deg.C, and 100 deg.C for 8min, and finding out that with the temperature rise, the soluble solid content in the extractive solution continuously rises, but the extraction rate of plant polysaccharide continuously falls, so the optimal extraction temperature is selected to be 80 deg.C.
Further, the extraction is performed at 40KHz frequency and 80 ℃ for 5min, 10min, 15min, 20min and 25min, and the extraction results are shown in FIG. 2, it can be found that the content of soluble solids in the leaching solution is continuously increased and tends to be stable along with the extension of the ultrasonic time, but the extraction rate of the plant polysaccharide is increased and then decreased. Therefore, the ultrasound time is controlled for another 10-15 minutes.
Transferring the extractive solution extracted at 40KHz frequency at 80 deg.C for 15min into an extraction tank, maintaining at 80 deg.C for 1 hr to increase the content of soluble solid by 1.3%, increasing the temperature maintaining time without obvious change, increasing the extraction rate of plant polysaccharide by 0.3%, and decreasing the temperature maintaining time.
Extracting at 80 deg.C at 40KHz frequency for 15min, keeping the temperature at 80 deg.C for 1 hr, concentrating, drying, granulating to obtain 63.9 g, adding 5g into 100mL water, stirring, dissolving within 30s to obtain yellow, clear and transparent solution.
Example 6:
extracting with ultrasonic extraction at 40KHz frequency and 80 deg.C for 15min, 25min and 35min respectively without soaking to obtain extractive solutions with soluble solid content of 23.1%, 24.4% and 25.8%, and plant polysaccharide extraction rate of 28.9%, 24.3% and 17.8%.
By comparison with example 5, it can be seen that soaking at 4-8 deg.C for 2h helps to reduce the ultrasonic extraction time and improve the effective extraction of plant polysaccharides.
Example 7:
soaking at 4-8 deg.C for 2 hr, extracting with ultrasonic extraction at 40KHz frequency to 80 deg.C for 15min, transferring into an extraction tank, maintaining at 80 deg.C for 1 hr, cooling to 25 deg.C within 30min via circulating cooling water pipeline, vacuumizing to 0.085-0.090MPa, and extracting under vacuum reduced pressure for 5min, 10min, and 15 min. The content of soluble solid in the extractive solution is respectively 26.9%, 28.8%, and 28.9%, and the extraction rate of plant polysaccharide is 31.9%, 32.1%, and 32.0%. Vacuum extracting under reduced pressure for 10min to obtain the best effect, concentrating, drying, granulating the extractive solution extracted under reduced pressure for 10min to obtain 74.6 g, adding 5g into 100mL water, stirring, dissolving within 30s to obtain yellow, clear and transparent solution.
Second, liver protection effect test of compound instant tea
Establishing a liver injury rat model by adopting a carbon tetrachloride liver injury model, and randomly dividing 60 rats into 6 groups, namely a group A, a normal control group and water; group B, model control group, water; group C, example 3, 5 mg/mL; group D, example 4, 5 mg/mL; group E, example 5, 5 mg/mL; group F, example 7, 5 mg/mL. Each group was administered the test substance by gavage daily at 10mL/kg (body weight) for 30 days continuously, weighing twice a week and adjusting the dose according to the body weight. After the end, the liver is taken to check the content of Malondialdehyde (MDA), reduced Glutathione (GSH) and Triglyceride (TG) in the liver homogenate.
The results are shown in table 1:
as can be seen from the above data, the water-soluble substance extracted from the above raw materials has the effect of protecting liver, and the effect of the extraction in example 7 is the best, and it is understood that the content of the effective component extracted in example 7 is the highest.
The above disclosure is only for the purpose of illustrating the preferred embodiments of the present invention, and it is therefore to be understood that the invention is not limited by the scope of the appended claims.
Claims (5)
1. A composite instant tea is characterized in that,
the raw materials comprise the following components:
90-110 parts of dendrobium officinale leaf, 27-33 parts of chrysanthemum, 45-55 parts of kudzu root, 18-22 parts of gardenia fruit and 4.5-5.5 parts of lophatherum gracile; 9-11 parts of cogongrass rhizome and 9-11 parts of houttuynia cordata;
the preparation process comprises the following steps:
(1) preparing and mixing raw materials;
(2) primary crushing: a medium-speed crusher is adopted, the rotating speed is 1000-;
(3) cleaning: cleaning the mixed raw materials after the primary crushing, and filtering to dry;
(4) extraction: adding the cleaned mixed raw materials into water for extraction;
(5) and (3) filtering: filtering to remove particles larger than 1 μm;
(6) concentrating;
(7) and (3) drying: drying by spray drying or freeze drying;
(8) and (3) granulation: granulating to form granules;
(9) drying;
(10) and (6) packaging.
2. The composite instant tea according to claim 1, wherein: the raw materials comprise the following components:
100 parts of dendrobium officinale leaf, 30 parts of chrysanthemum, 50 parts of kudzu root, 20 parts of gardenia fruit and 5 parts of lophatherum gracile; 10 parts of cogongrass rhizome, 10 parts of houttuynia cordata and 15 parts of dried momordica cochinchinensis fruit.
3. The composite instant tea according to claim 1, wherein: in the step (4), the extraction process comprises soaking, heating and ultrasonic leaching, and finally vacuum decompression extraction.
4. The composite instant tea according to claim 3, wherein: in the step (4), the extraction process is as follows:
(4-1) soaking at 4-8 ℃;
(4-2) ultrasonic leaching: heating to 60-100 deg.C, ultrasonic extracting, and keeping the temperature;
(4-3) leaching under reduced pressure: rapidly cooling to below 25 deg.C, and vacuum extracting under reduced pressure.
5. The composite instant tea according to claim 4, wherein: in the step (4-2), the mixture is heated to 80 ℃, is subjected to ultrasonic leaching for 10 to 15 minutes at the frequency of 40KHZ, is placed into an extraction tank, and is kept at the temperature of 80 ℃ for 1 hour.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010895286.XA CN111990510B (en) | 2020-08-31 | 2020-08-31 | Composite instant tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010895286.XA CN111990510B (en) | 2020-08-31 | 2020-08-31 | Composite instant tea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111990510A true CN111990510A (en) | 2020-11-27 |
| CN111990510B CN111990510B (en) | 2023-05-02 |
Family
ID=73464765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010895286.XA Active CN111990510B (en) | 2020-08-31 | 2020-08-31 | Composite instant tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111990510B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106668144A (en) * | 2016-10-11 | 2017-05-17 | 刘艳平 | Chinese herbal medicine blood pressure reducing tea and preparation method thereof |
| CN107854681A (en) * | 2017-12-23 | 2018-03-30 | 芜湖皖江知识产权运营中心有限公司 | A kind of anti-inflammatory composition and preparation method thereof |
| CN108066382A (en) * | 2017-11-10 | 2018-05-25 | 湖北瀚思生物科技有限公司 | A kind of gold and silver alantol functional beverage and its production method |
| CN108552372A (en) * | 2017-12-27 | 2018-09-21 | 温州科技职业学院 | A kind of particle tea bag and preparation method thereof |
| JP2019523307A (en) * | 2016-08-04 | 2019-08-22 | ペキン ボォシン ネイチャー バイオテック リミテッド | Method for preparing active extract and its application |
-
2020
- 2020-08-31 CN CN202010895286.XA patent/CN111990510B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019523307A (en) * | 2016-08-04 | 2019-08-22 | ペキン ボォシン ネイチャー バイオテック リミテッド | Method for preparing active extract and its application |
| CN106668144A (en) * | 2016-10-11 | 2017-05-17 | 刘艳平 | Chinese herbal medicine blood pressure reducing tea and preparation method thereof |
| CN108066382A (en) * | 2017-11-10 | 2018-05-25 | 湖北瀚思生物科技有限公司 | A kind of gold and silver alantol functional beverage and its production method |
| CN107854681A (en) * | 2017-12-23 | 2018-03-30 | 芜湖皖江知识产权运营中心有限公司 | A kind of anti-inflammatory composition and preparation method thereof |
| CN108552372A (en) * | 2017-12-27 | 2018-09-21 | 温州科技职业学院 | A kind of particle tea bag and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111990510B (en) | 2023-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104041896A (en) | Medicine and food homologous plant concentrated juice and preparation method thereof | |
| CN105767397A (en) | Spleen-invigorating and stomach-harmonizing gingko tea | |
| CN113730479A (en) | Composition with health care function and preparation method and application thereof | |
| CN107897418A (en) | A kind of health preserving tea and preparation method thereof | |
| CN106362004A (en) | Compound fresh dendrobium nobile granules and preparation method thereof | |
| CN103636861A (en) | Skin-nourishing and calculi-eliminating tea | |
| CN105994735A (en) | Semen ginkgo tea for refreshing brain and restoring consciousness | |
| CN111990510B (en) | Composite instant tea | |
| CN105876017A (en) | Ginkgo health tea | |
| CN114767826A (en) | Sobering-up and liver-protecting composition, beverage with sobering-up and liver-protecting effects and preparation method of beverage | |
| CN107753602A (en) | A kind of Chinese medicine composition for treating leukaemia and preparation method thereof | |
| CN103704409B (en) | A kind of cold tea and preparation method thereof | |
| CN106387215A (en) | Radix puerariae and cordyceps militaris tea and preparation method thereof | |
| CN112690382A (en) | Beverage capable of clearing away heat and toxic materials | |
| CN112168944A (en) | Traditional Chinese medicine composition and extract for preventing new coronary pneumonia, and preparation method and application thereof | |
| CN115006460B (en) | Traditional Chinese medicine composition for dispelling effects of alcohol and protecting liver as well as preparation method and application thereof | |
| CN110917320A (en) | Acupoint-opening and relieving essential oil and preparation method thereof | |
| AU2020101678A4 (en) | A health care drink and preparation method thereof | |
| CN111728061A (en) | Scented tea and making method thereof | |
| CN115837064A (en) | Traditional Chinese medicine formula for softening hyperplasia scars and preparation method thereof | |
| CN105876035A (en) | Radix Puerariae heat clearing-way and sunstroke preventing tea and preparation method thereof | |
| CN114984150A (en) | Eye-protecting and eyesight-improving herbal plant atomized essential oil and preparation method thereof | |
| CN108850320A (en) | The assorted instant compound tea of standard quantitative, preparation method and method for pouring | |
| CN102961681A (en) | Chinese patent medicine for treating viral myocarditis | |
| CN114146145A (en) | Cold-dispelling dampness-eliminating tendon-relaxing collateral-dredging herbal essence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |